Gianni Bisogno
- Pulmonary and Respiratory Medicine top 0.2%
- Surgery top 1%
- Oncology top 1%
- Pathology and Forensic Medicine top 0.5%
- Rheumatology top 0.5%
- Co-authors
- Andrea FerrariModesto CarliGiovanni CecchettoMichela CasanovaRita AlaggioDaniel OrbachGian Luca De SalvoPatrizia Dall’Igna
- Topics
- Sarcoma Diagnosis and Treatment (203 papers)Tumors and Oncological Cases (69 papers)Testicular diseases and treatments (38 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ItalyFranceUnited Kingdom
In The Last Decade
Gianni Bisogno
322 papers receiving 8.0k citations
Peers
Comparison fields: 5 of 123
- Pulmonary and Respiratory Medicine 5.2k
- Surgery 2.6k
- Oncology 2.4k
- Pathology and Forensic Medicine 2.1k
- Rheumatology 1.8k
Countries citing papers authored by Gianni Bisogno
This map shows the geographic impact of Gianni Bisogno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianni Bisogno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianni Bisogno more than expected).
Fields of papers citing papers by Gianni Bisogno
This network shows the impact of papers produced by Gianni Bisogno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianni Bisogno. The network helps show where Gianni Bisogno may publish in the future.
Co-authorship network of co-authors of Gianni Bisogno
This figure shows the co-authorship network connecting the top 25 collaborators of Gianni Bisogno. A scholar is included among the top collaborators of Gianni Bisogno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianni Bisogno. Gianni Bisogno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 8 | |
| 7 | 1 | |
| 8 | 10 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 8 | |
| 12 | 6 | |
| 13 | 11 | |
| 14 | 1 | |
| 15 | 8 | |
| 16 | 2 | |
| 17 | 9 | |
| 18 | 41 | |
| 19 | 19 | |
| 20 | 16 |
About Gianni Bisogno
Gianni Bisogno is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Rheumatology, having authored 336 papers that have together received 8.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (203 papers), Tumors and Oncological Cases (69 papers) and Testicular diseases and treatments (38 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.2k citations), Pathology and Forensic Medicine (2.1k citations) and Rheumatology (1.8k citations). Gianni Bisogno has collaborated with scholars based in Italy, France and United Kingdom. Frequent co-authors include Andrea Ferrari, Modesto Carli, Giovanni Cecchetto, Michela Casanova, Rita Alaggio, Daniel Orbach, Gian Luca De Salvo, Patrizia Dall’Igna, Ilaria Zanetti and Michaël C.G. Stevens. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.